A Plea for Neutral Comparison Studies in Computational SciencesAnne‐Laure Boulesteix, Manuel J. A. Eugster, Sabine Lauer|PLoS ONE|2013Cited by 149
Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patientsJoseph Gligorov, Luis Matamala, N. Al-Sakaff et al.|European Journal of Cancer|2017Cited by 47
A Statistical Framework for Hypothesis Testing in Real Data Comparison StudiesAnne‐Laure Boulesteix, Manuel J. A. Eugster, Robert Hable et al.|The American Statistician|2015Cited by 39